Group One Trading
EIGR

Group One Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Group One Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-553
Closed -$11.7K – 8509
2023
Q2 		$11.7K Sell
553
-350
-39% -$10.8K ﹤0.01% 6311
2023
Q1 		$24.3K Buy
903
+670
+288% +$31.2K ﹤0.01% 5380
2022
Q4 		$8.26K Buy
233
+226
+3,229% +$27.1K ﹤0.01% 6105
2022
Q3 		$2K Buy
7
+4
+133% +$983 ﹤0.01% 7230
2022
Q2 		$1K Sell
3
-1,980
-100% -$399K ﹤0.01% 7663
2022
Q1 		$494K Buy
1,983
+1,950
+5,909% +$308K ﹤0.01% 3832
2021
Q4 		$5K Sell
33
-1,150
-97% -$222K ﹤0.01% 7664
2021
Q3 		$237K Sell
1,183
-4,820
-80% -$1.15M ﹤0.01% 4997
2021
Q2 		$1.53M Buy
6,003
+2,766
+85% +$690K ﹤0.01% 2920
2021
Q1 		$859K Buy
+3,237
New +$1.02M ﹤0.01% 3412
2020
Q4 		– Sell
-3
Closed -$1K – 7139
2020
Q3 		$1K Buy
+3
New +$933 ﹤0.01% 5972
2015
Q4 		– Sell
-1,496
Closed -$707K – 5187
2015
Q3 		$707K Sell
1,496
-427
-22% -$226K 0.01% 1515
2015
Q2 		$1.09M Buy
1,923
+1,658
+626% +$4.59M 0.02% 1150
2015
Q1 		$2.26M Buy
+265
New +$2.32M 0.04% 577

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's EIGR Position: Q1 2023 in Review

Group One Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 409 shares — an estimated $19K sold.

Group One Trading first reported a position in EIGR in Q2 2015 and held it in 13 quarters. The position peaked at $72K in Q1 2022. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

  • Group One Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 409 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $19K.
  • Group One Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
  • Group One Trading's Eiger BioPharmaceuticals, Inc. position peaked at $72K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.